• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    ZIOPHARM Oncology, Inc. (ZIOP)

    -NasdaqCM
    10.77 Down 0.84(7.24%) Mar 31, 4:00PM EDT
    |After Hours : 10.70 Down 0.07 (0.65%) Mar 31, 7:57PM EDT
    Add to Portfolio
    Prev Close:11.61
    Open:11.52
    Bid:10.70 x 400
    Ask:11.25 x 1000
    1y Target Est:16.67
    Beta:0.49
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:10.72 - 11.61
    52wk Range:2.31 - 14.40
    Volume:6,246,223
    Avg Vol (3m):4,990,090
    Market Cap:1.12B
    P/E (ttm):N/A
    EPS (ttm):-0.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ZIOP

    Comparison

    Symbol% ChgMkt Cap
    ZIOPDown 7.24%1.12B
    IMGNUp 5.05%770.66M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):882.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing cancer therapies. The company is employing novel gene expression, and control and cells technologies to deliver cell-based therapies for the tr... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback